NCT06131892

Brief Summary

Hypothermia (core temperature ≤35°C) is a frequent and life-threatening complication after mountain accidents, near-drowning, and intoxications, and can provoke arrhythmia, reduced cardiac contractility, and cardiac arrest. The hypothermic heart may be insensitive to defibrillation with a core temperature \<30°C. Also, below \<30°C after successful defibrillation, a perfusing rhythm often degenerates to ventricular fibrillation (VF) again. Repeated defibrillation can induce myocardial injury. Thus, the guidelines of the European Resuscitation Council (ERC) suggest delaying further defibrillation attempts until the core temperature is \>30°C if VF persists after 3 shocks. Epinephrine should be withheld if core temperature is \<30°C. Advanced Life Support (ALS) guidelines of the American Heart Association (AHA) state that it may be reasonable to perform further defibrillation attempts according to the standard algorithm and to consider administration of a vasopressor during cardiac arrest (Table 1). This discrepancy between ERC and AHA guidelines can be explained by the different interpretations of mainly animal data, which show that vasopressors increase the chances of successful defibrillation \<30°C, defined as return of spontaneous circulation (ROSC) for at least 30 seconds. The guidelines of the Wilderness and Environmental Medicine Society (WMS) state that a single shock at a maximum power can be given for patients with a temperature \<30°C. The aim of this study is to evaluate clinical course of hypothermic patients(\<30°C) undergoing defibrillation. The primary aim is to evaluate the success ratio of defibrillation, defined as ROSC for at least 30 seconds. Secondary aims are the recurrence rate of ventricular fibrillation, the number of defibrillation attempts per patient, the presence of cardiac dysfunction after defibrillation and the cerebral performance category (CPC) score at the end of hospitalization.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
63

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2023

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

October 22, 2023

Completed
23 days until next milestone

First Posted

Study publicly available on registry

November 14, 2023

Completed
Last Updated

November 18, 2023

Status Verified

November 1, 2023

Enrollment Period

6 months

First QC Date

October 22, 2023

Last Update Submit

November 14, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • the number of patients with a core temperature equal or less than 30°C who had a successful defibrillation, defined as ROSC for at least 30 seconds

    through study completion, an average of 3 months

Secondary Outcomes (4)

  • the number of patients with a return to ventricular fibrillation after successful defibrillation

    through study completion, an average of 3 months

  • the rate of defibrillation attempts per patient

    through study completion, an average of 3 months

  • the number of patients with the presence of cardiac dysfunction after defibrillation

    through study completion, an average of 3 months

  • cerebral performance category (CPC) score of every patient at the end of hospitalization

    through study completion, an average of 3 months

Study Arms (4)

Successful defibrillation during extra corporeal life support (ECLS) rewarming

Other: Defibrillation

Non Successful defibrillation during extra corporeal life support (ECLS) rewarming

Other: Defibrillation

Successful defibrillation before rewarming or during non-ECLS rewarming

non- ECLS: non- extra corporeal life support

Other: Defibrillation

Non- successful defibrillation before rewarming or during non-ECLS rewarming

non- ECLS: non- extra corporeal life support

Other: Defibrillation

Interventions

Defibrillation

Non Successful defibrillation during extra corporeal life support (ECLS) rewarmingNon- successful defibrillation before rewarming or during non-ECLS rewarmingSuccessful defibrillation before rewarming or during non-ECLS rewarmingSuccessful defibrillation during extra corporeal life support (ECLS) rewarming

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with accidental hypothermia and a body core temperature equal or less than 30°C who had one or more defibrillation attempts

You may qualify if:

  • \- patients of the International Hypothermia Registry with a defibrillation while having a body core temperature equal or less than 30°C

You may not qualify if:

  • patients of the International Hypothermia Registry with a body core temperature \>30°C
  • patients who refused to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Division of Anaesthesiology

Geneva, Switzerland

Location

MeSH Terms

Conditions

Hypothermia

Interventions

Electric Countershock

Condition Hierarchy (Ancestors)

Body Temperature ChangesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeutics

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor, Principal Investigator

Study Record Dates

First Submitted

October 22, 2023

First Posted

November 14, 2023

Study Start

April 1, 2023

Primary Completion

September 30, 2023

Study Completion

September 30, 2023

Last Updated

November 18, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations